A Single Centre, Open-label, 2-period Fixed-sequence, Phase I Clinical Study to Evaluate the Effect of BV100 on the Pharmacokinetics of Polymyxin B in Healthy Volunteers
Recruiting now · Phase 1
Conditions studied: Healthy Adult Participants
In brief
This is an open-label, fixed sequence Phase I clinical study to evaluate the effect of multiple doses of BV100 on the PK of polymyxin B in healthy participants (HPs).
Key facts
- Study ID
- NCT07580586
- Run by
- BioVersys SAS
- People needed
- 16
- Starts
- 2026-03-22
- Expected to finish
- 2026-12-30
- Last updated by the study team
- 2026-05-12
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Medical University of Vienna — Vienna, Austria (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.